These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 15959874

  • 1. Maternal fumonisin exposure and risk for neural tube defects: mechanisms in an in vivo mouse model.
    Gelineau-van Waes J, Starr L, Maddox J, Aleman F, Voss KA, Wilberding J, Riley RT.
    Birth Defects Res A Clin Mol Teratol; 2005 Jul; 73(7):487-97. PubMed ID: 15959874
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Elevated nuclear sphingoid base-1-phosphates and decreased histone deacetylase activity after fumonisin B1 treatment in mouse embryonic fibroblasts.
    Gardner NM, Riley RT, Showker JL, Voss KA, Sachs AJ, Maddox JR, Gelineau-van Waes JB.
    Toxicol Appl Pharmacol; 2016 May 01; 298():56-65. PubMed ID: 26905748
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reproductive and sphingolipid metabolic effects of fumonisin B(1) and its alkaline hydrolysis product in LM/Bc mice: hydrolyzed fumonisin B(1) did not cause neural tube defects.
    Voss KA, Riley RT, Snook ME, Waes JG.
    Toxicol Sci; 2009 Dec 01; 112(2):459-67. PubMed ID: 19783636
    [Abstract] [Full Text] [Related]

  • 7. A blood spot method for detecting fumonisin-induced changes in putative sphingolipid biomarkers in LM/Bc mice and humans.
    Riley RT, Showker JL, Lee CM, Zipperer CE, Mitchell TR, Voss KA, Zitomer NC, Torres O, Matute J, Gregory SG, Ashley-Koch AE, Maddox JR, Gardner N, Gelineau-Van Waes JB.
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2015 Dec 01; 32(6):934-49. PubMed ID: 25833119
    [Abstract] [Full Text] [Related]

  • 8. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize.
    Marasas WF, Riley RT, Hendricks KA, Stevens VL, Sadler TW, Gelineau-van Waes J, Missmer SA, Cabrera J, Torres O, Gelderblom WC, Allegood J, Martínez C, Maddox J, Miller JD, Starr L, Sullards MC, Roman AV, Voss KA, Wang E, Merrill AH.
    J Nutr; 2004 Apr 01; 134(4):711-6. PubMed ID: 15051815
    [Abstract] [Full Text] [Related]

  • 9. Increased sphingoid base-1-phosphates and failure of neural tube closure after exposure to fumonisin or FTY720.
    Gelineau-van Waes J, Rainey MA, Maddox JR, Voss KA, Sachs AJ, Gardner NM, Wilberding JD, Riley RT.
    Birth Defects Res A Clin Mol Teratol; 2012 Oct 01; 94(10):790-803. PubMed ID: 22991331
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevention of fumonisin B1-induced neural tube defects by folic acid.
    Sadler TW, Merrill AH, Stevens VL, Sullards MC, Wang E, Wang P.
    Teratology; 2002 Oct 01; 66(4):169-76. PubMed ID: 12353213
    [Abstract] [Full Text] [Related]

  • 12. Fumonisin B1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor.
    Stevens VL, Tang J.
    J Biol Chem; 1997 Jul 18; 272(29):18020-5. PubMed ID: 9218430
    [Abstract] [Full Text] [Related]

  • 13. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
    Voss KA, Liu J, Anderson SP, Dunn C, Miller JD, Owen JR, Riley RT, Bacon CW, Corton JC.
    Toxicol Sci; 2006 Jan 18; 89(1):108-19. PubMed ID: 16221962
    [Abstract] [Full Text] [Related]

  • 14. Extrusion cooking with glucose supplementation of fumonisin-contaminated corn grits protects against nephrotoxicity and disrupted sphingolipid metabolism in rats.
    Voss KA, Riley RT, Jackson LS, Jablonski JE, Bianchini A, Bullerman LB, Hanna MA, Ryu D.
    Mol Nutr Food Res; 2011 Sep 18; 55 Suppl 2():S312-20. PubMed ID: 21648070
    [Abstract] [Full Text] [Related]

  • 15. Lack of embryotoxicity of fumonisin B1 in New Zealand white rabbits.
    LaBorde JB, Terry KK, Howard PC, Chen JJ, Collins TF, Shackelford ME, Hansen DK.
    Fundam Appl Toxicol; 1997 Nov 18; 40(1):120-8. PubMed ID: 9398494
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of tumor necrosis factor alpha signaling by anti-tumor necrosis factor alpha antibodies and pentoxifylline is unable to prevent fumonisin hepatotoxicity in mice.
    He Q, Sharma RP.
    Toxicon; 2005 Sep 15; 46(4):404-13. PubMed ID: 16054185
    [Abstract] [Full Text] [Related]

  • 17. Effects of folate supplementation on the risk of spontaneous and induced neural tube defects in Splotch mice.
    Gefrides LA, Bennett GD, Finnell RH.
    Teratology; 2002 Feb 15; 65(2):63-9. PubMed ID: 11857507
    [Abstract] [Full Text] [Related]

  • 18. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
    He Q, Suzuki H, Sharma N, Sharma RP.
    Toxicol Sci; 2006 Dec 15; 94(2):388-97. PubMed ID: 16960033
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Investigations into the etiology of neural tube defects.
    Cabrera RM, Hill DS, Etheredge AJ, Finnell RH.
    Birth Defects Res C Embryo Today; 2004 Dec 15; 72(4):330-44. PubMed ID: 15662706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.